Loss of Bach2 in T cells causes prolonged allergic inflammation through accumulation of effector T cells and disruption of epidermal barrier
Open Access
- 7 February 2025
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 155 (6) , 2009-2021.e6
Abstract
No abstract availableKeywords
Funding Information
- JSPS (21K08205)
- Hoyu Science Foundation
- Takeda Science Foundation
- Ehime University
- Japan Society for the Promotion of Science (21K08205, 23H02736, 22K08433)
This publication has 46 references indexed in Scilit:
- Super‐killer CTLs are generated by single gene deletion of Bach2European Journal of Immunology, 2022
- The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targetsArchives of Dermatological Research, 2019
- Roles of alternatively activated M2 macrophages in allergic contact dermatitisAllergology International, 2017
- Innate lymphoid cells in allergic and nonallergic inflammationJournal of Allergy and Clinical Immunology, 2016
- Repression of the Transcription Factor Bach2 Contributes to Predisposition of IgG1 Memory B Cells toward Plasma Cell DifferentiationImmunity, 2013
- Atopic dermatitis results in intrinsic barrier and immune abnormalities: Implications for contact dermatitisJournal of Allergy and Clinical Immunology, 2013
- Plasticity of Foxp3+ T Cells Reflects Promiscuous Foxp3 Expression in Conventional T Cells but Not Reprogramming of Regulatory T CellsImmunity, 2012
- Suppression assays with human T regulatory cells: A technical guideEuropean Journal of Immunology, 2011
- Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalitiesJournal of Allergy and Clinical Immunology, 2011
- Proliferative activation up‐regulates expression of CD4 and HIV‐1 co‐receptors on NK cells and induces their infection with HIV‐1European Journal of Immunology, 2007